mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study) (preDIABETEXT)
Prediabetic State
About this trial
This is an interventional prevention trial for Prediabetic State focused on measuring Prediabetic State, Glycemic Control, Telemedicine
Eligibility Criteria
ELIGIBILITY CRITERIA FOR PRIMARY HEALTHCARE WORKERS:
We will include physicians and nurses from primary care centres in Mallorca. We will exclude those anticipating moving to a different centre during the study period.
ELIGIBILITY CRITERIA FOR PATIENTS:
Inclusion Criteria:
- Registered in the Public Health Service of the Balearic Islands
- At risk of T2DM (HbA1c from 6% to 6.4% within the last 3 months or two consecutive values of fasting plasma glucose 110-125mg/dl within the last 12 months, or both)
- With access to a mobile device able to receive text messages.
Exclusion Criteria:
- People not able to read messages in Spanish
- Patients with severe mental conditions.
- Patients on an antidiabetic medication regime
- Pregnancy: currently or during the previous 12 months
- People planning to change healthcare centre during the intervention period
Sites / Locations
- Ignacio Ricci-Cabello
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Intervention A
Intervention B
Control
Participants will receive Messaging Intervention
Participants will receive messaging intervention plus online education to their primary healthcare workers
Participants will receive usual care only, and their healthcare workers will not receive online education